COVID-19-assoziierte Herzrhythmusstörungen

Marcel Feher; Julia Vogler; Roland Richard Tilz

doi:10.1055/a-1764-5085

Kardiologie up2date, Table of Contents

Kardiologie up2date 2022; 18(04): 329-344
DOI: 10.1055/a-1764-5085

Herzrhythmusstörungen

COVID-19-assoziierte Herzrhythmusstörungen

Marcel Feher

,

Julia Vogler

,

Roland Richard Tilz

Abstract

All articles of this category

Ein schwerer Krankheitsverlauf im Rahmen einer COVID-19-Infektion kann mit bradykarden und tachykarden Herzrhythmusstörungen einhergehen. Die Pathomechanismen für die Manifestation der Herzrhythmusstörungen sind dementsprechend vielfaltig und teilweise nicht ganz verstanden. Folgend werden COVID-19-assoziierte Herzrhythmusstörungen mit Bezug auf ihre Epidemiologie, mögliche Pathomechanismen und ihr Management beschrieben.

Schlüsselwörter

COVID-19 - Herzrhythmusstörung - Arrhythmie - Pathomechanismen - Tachykardie-Syndrom

Full Text

References

Literatur
1 Robert Koch-Institut. RKI – Coronavirus SARS-CoV-2 – COVID-19: Fallzahlen in Deutschland und weltweit. Accessed September 11, 2022 at: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Fallzahlen.html%20Stand%2004/2022
2 World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Accessed September 11, 2022 at: https://covid19.who.int
3 Li H, Burm SW, Hong SH. et al. A Comprehensive Review of Coronavirus Disease 2019: Epidemiology, Transmission, Risk Factors, and International Responses. Yonsei Med J 2021; 62: 1-11
4 Lai CC, Liu YH, Wang CY. et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J Microbiol Immunol Infect 2020; 53: 404-412
5 Lai CC, Ko WC, Lee PI. et al. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents 2020; 56: 106024
6 Shi S, Qin M, Shen B. et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol 2020; 5: 802
7 Peltzer B, Manocha KK, Ying X. et al. Arrhythmic Complications of Patients Hospitalized With COVID-19: Incidence, Risk Factors, and Outcomes. Circ Arrhythm Electrophysiol 2020; 13: e009121
8 Turagam MK, Musikantow D, Goldman ME. et al. Malignant Arrhythmias in Patients With COVID-19: Incidence, Mechanisms, and Outcomes. Circ Arrhythm Electrophysiol 2020; 13: e008920
9 Task Force for the management of COVID-19 of the European Society of Cardiology. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Cardiovasc Res 2022; 118: 1618-1666
10 Kochav SM, Coromilas E, Nalbandian A. et al. Cardiac Arrhythmias in COVID-19 Infection. Circ Arrhythm Electrophysiol 2020; 13: e008719
11 Wang D, Hu B, Hu C. et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020; 323: 1061-1069
12 Gopinathannair R, Merchant FM, Lakkireddy DR. et al. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol 2020; 59: 329-336
13 Boriani G, Fauchier L, Aguinaga L. et al. European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS). Europace 2019; 21: 7-8
14 Al-Assaf O, Mirza M, Musa A. Atypical presentation of COVID-19 as subclinical myocarditis with persistent high-degree atrioventricular block treated with pacemaker implant. HeartRhythm Case Rep 2020; 6: 884-887
15 Goyal P, Choi JJ, Pinheiro LC. et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med 2020; 382: 2372-2374
16 Colon CM, Barrios JG, Chiles JW. et al. Atrial Arrhythmias in COVID-19 Patients. JACC Clin Electrophysiol 2020; 6: 1189-1190
17 Peltzer B, Manocha KK, Ying X. et al. Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19. J Cardiovasc Electrophysiol 2020; 31: 3077-3085
18 Szarpak L, Filipiak KJ, Skwarek A. et al. Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19: A systematic review and meta-analysis. Cardiol J 2022; 29: 33-43
19 Xie Y, Xu E, Bowe B. et al. Long-term cardiovascular outcomes of COVID-19. Nat Med 2022; 28: 583-590
20 Guo T, Fan Y, Chen M. et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol 2020; 5: 811
21 Baldi E, Sechi GM, Mare C. et al. Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy. N Engl J Med 2020; 383: 496-498
22 Lim ZJ, Ponnapa Reddy M, Afroz A. et al. Incidence and outcome of out-of-hospital cardiac arrests in the COVID-19 era: A systematic review and meta-analysis. Resuscitation 2020; 157: 248-258
23 Nalbandian A, Sehgal K, Gupta A. et al. Post-acute COVID-19 syndrome. Nat Med 2021; 27: 601-615
24 Ståhlberg M, Reistam U, Fedorowski A. et al. Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome. Am J Med 2021; 134: 1451-1456
25 Kochi AN, Tagliari AP, Forleo GB. et al. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol 2020; 31: 1003-1008
26 Babapoor-Farrokhran S, Gill D, Walker J. et al. Myocardial injury and COVID-19: Possible mechanisms. Life Sci 2020; 253: 117723
27 Lazzerini PE, Boutjdir M, Capecchi PL. COVID-19, Arrhythmic Risk, and Inflammation: Mind the Gap!. Circulation 2020; 142: 7-9
28 Siripanthong B, Nazarian S, Muser D. et al. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm 2020; 17: 1463-1471
29 Peretto G, Sala S, Rizzo S. et al. Arrhythmias in myocarditis: State of the art. Heart Rhythm 2019; 16: 793-801
30 Wrapp D, Wang N, Corbett KS. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020; 367: 1260-1263
31 Vaduganathan M, Vardeny O, Michel T. et al. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med 2020; 382: 1653-1659
32 Aimo A, Baritussio A, Emdin M. et al. Amiodarone as a possible therapy for coronavirus infection. Eur J Prev Cardiol 2021; 28: e16-e18
33 Tse G, Yeo JM, Chan YW. et al. What Is the Arrhythmic Substrate in Viral Myocarditis? Insights from Clinical and Animal Studies. Front Physiol 2016; 7: 308
34 Lazzerini PE, Capecchi PL, Laghi-Pasini F. Long QT Syndrome: An Emerging Role for Inflammation and Immunity. Front Cardiovasc Med 2015; 2: 26
35 Lazzerini PE, Laghi-Pasini F, Boutjdir M. et al. Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies. Nat Rev Immunol 2019; 19: 63-64
36 Lazzerini PE, Acampa M, Capecchi PL. et al. Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation. Arthritis Care Res (Hoboken) 2015; 67: 332-339
37 Tang N, Li D, Wang X. et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18: 844-847
38 Hunt BJ. Bleeding and Coagulopathies in Critical Care. N Engl J Med 2014; 370: 847-859
39 Huertas A, Montani D, Savale L. et al. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?. Eur Respir J 2020; 56: 2001634
40 Varga Z, Flammer AJ, Steiger P. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020; 395: 1417-1418
41 Bangalore S, Sharma A, Slotwiner A. et al. ST-Segment Elevation in Patients with Covid-19 – A Case Series. N Engl J Med 2020; 382: 2478-2480
42 Musher DM, Abers MS, Corrales-Medina VF. Acute Infection and Myocardial Infarction. N Engl J Med 2019; 380: 171-176
43 Klok FA, Kruip MJHA, van der Meer NJM. et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020; 191: 145-147
44 Ñamendys-Silva SA, Santos-Martínez LE, Pulido T. et al. Pulmonary hypertension due to acute respiratory distress syndrome. Braz J Med Biol Res 2014; 47: 904-910
45 Wanamaker B, Cascino T, McLaughlin V. et al. Atrial Arrhythmias in Pulmonary Hypertension: Pathogenesis, Prognosis and Management. Arrhythm Electrophysiol Rev 2018; 7: 43-48
46 Alreshq R, Hsu G, Torosoff M. Acute Pulmonary Embolism Presenting with Symptomatic Bradycardia: A Case Report and Review of the Literature. Am J Case Rep 2019; 20: 748-752
47 Surawicz B. Role of electrolytes in etiology and management of cardiac arrhythmias. Prog Cardiovasc Dis 1966; 8: 364-386
48 Lippi G, South AM, Henry BM. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann Clin Biochem 2020; 57: 262-265
49 Gabarre P, Dumas G, Dupont T. et al. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med 2020; 46: 1339-1348
50 Gaber Y. Diarrhoea and the COVID-19 pandemic. Arab J Gastroenterol 2020; 21: 146-150
51 Bosch NA, Cimini J, Walkey AJ. Atrial Fibrillation in the ICU. Chest 2018; 154: 1424-1434
52 Giudicessi JR, Noseworthy PA, Friedman PA. et al. Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19). Mayo Clin Proc 2020; 95: 1213-1221
53 Erickson TB, Chai PR, Boyer EW. Chloroquine, hydroxychloroquine and COVID-19. Toxicol Commun 2020; 4: 40-42
54 Nabati M, Parsaee H. Potential Cardiotoxic Effects of Remdesivir on Cardiovascular System: A Literature Review. Cardiovasc Toxicol 2022; 22: 268-272
55 Sakabe M, Yoshioka R, Fujiki A. Sick sinus syndrome induced by interferon and ribavirin therapy in a patient with chronic hepatitis C. J Cardiol Cases 2013; 8: 173-175
56 Dherange P, Lang J, Qian P. et al. Arrhythmias and COVID-19: A Review. JACC Clin Electrophysiol 2020; 6: 1193-1204